Related Experiment Video
Updated: Apr 13, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Novel Inflammatory Biomarkers in Cardiovascular Therapeutics
Insights
Novel inflammatory biomarkers aid cardiovascular disease management. This review explores their role in guiding therapeutic decisions for better patient outcomes and risk stratification.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biomarker Research
Background:
- Inflammation is a key factor in cardiovascular disease (CVD) progression.
- Current diagnostic and monitoring tools for CVD include clinical exams, lab tests, and imaging.
- Novel inflammatory biomarkers help in patient risk stratification.
Purpose of the Study:
- To review the latest data on using inflammatory biomarkers in cardiovascular therapeutics.
- To evaluate the potential of inflammatory biomarkers in guiding treatment decisions for CVD patients.
Main Methods:
- Literature review of recent studies on inflammatory biomarkers and cardiovascular therapeutics.
- Analysis of data concerning the application of biomarkers in patient management.
Main Results:
- Inflammatory biomarkers are increasingly used for CVD risk stratification.
- Evidence for their role in guiding specific treatment decisions is still under extensive evaluation.
Conclusions:
- Inflammatory biomarkers show promise in refining cardiovascular risk assessment.
- Further research is needed to fully establish their utility in guiding therapeutic strategies for cardiovascular diseases.
Abstract:
Inflammation has been established as an important determinant of cardiovascular disease progression. Currently, clinical examination, laboratory and imaging tests are invaluable for the diagnosis, prognosis and disease monitoring. Novel inflammatory biomarkers are also used to better restratify patients in risk groups but their potential to guide treatment decisions and management of patients has not been extensively evaluated. Therefore, in this review article we present the most recent data concerning the use of inflammatory biomarkers in cardiovascular therapeutics.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Inflammatory Response I: Vascular and Cellular
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Cardiovascular Drugs: Classification based on Therapeutic Indications

